Annals of Oncology, Volume 24, suppl. 4, REGARD PHASE 3,RANDOMIZED TRIAL OF RAMUCIRUMAB IN PATIENTS WITH METASTATICGASTRIC OR GEJ ADENOCARCINOMA FOLLOWING PROGRESSION ONFIRST-LINE CHEMOTHERAPY